- Knowledge Central
The next big fear for biotech: a “delisting” letter from the Nasdaq
The latest fear plaguing biotech boardrooms isn’t a failed experiment or a huge financial push,…Read More
Why are most clinical trials failing because of the impact of AI?
Artificial intelligence (AI) research in healthcare is growing, with potential applications being proven across a…Read More
Astellas New Menopause Drug Fails to Gain FDA Approval.
Astellas’ effort to launch menopause drug candidate fezolinetant hit a snag at the last minute.…Read More
John Reed soars to the top of the ladder at J&J
John Reed, M.D., Ph.D., Head of Global R&D at Sanofi, has moved to Johnson &…Read More
Mineralys Upsizes IPO to raise $192M, Seeks to Race Ahead of AstraZeneca
After a long winter, the first signs of spring have brought a smaller patch of…Read More
Early cancer detection: The key to saving lives
Most cancers are quickly turning into an “epidemic” and are the second main explanation for…Read More
Four major mRNA vaccine clinical trials to watch in 2023.
Following the success of messenger RNA (mRNA) vaccines for COVID-19, there has been more investment…Read More
Can AI really live up to its hype in pharma and life sciences?
By 2025, the pharmaceutical industry is expected to spend more than $3 billion on AI,…Read More
AI-enabled “Zinc fingers” could help customize treatment for diseases.
n artificial intelligence (AI) program may enable the first simple production of customizable proteins called…Read More